ICM
APTV icon

Invenomic Capital Management’s Aptiv APTV Stock Holding History

Invenomic Capital Management’s Portfolio APTV Stock Details APTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-378,306
Closed -$26.6M – 144
2024
Q2 		$26.6M Buy
+378,306
New +$29.1M 1.3% 19

Other funds holding APTV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Invenomic Capital Management's APTV Position: Q3 2024 in Review

Invenomic Capital Management sold out of Aptiv (APTV) in Q3 2024, closing a stake of 378,306 shares — an estimated $26.6M sold.

Invenomic Capital Management first reported a position in APTV in Q2 2024 and held it in 1 quarter. The position peaked at $26.6M in Q2 2024. 719 funds tracked by Wall St. Rank hold APTV as of Q3 2024.

  • Invenomic Capital Management reported no remaining Aptiv position as of Q3 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 378,306 Aptiv shares in Q3 2024, an estimated $26.6M.
  • Invenomic Capital Management first reported a position in Aptiv in Q2 2024 and held it in 1 quarter.
  • Invenomic Capital Management's Aptiv position peaked at $26.6M in Q2 2024.
  • 719 funds tracked by Wall St. Rank held Aptiv as of Q3 2024.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.